As secondary outcomes, we also want to evaluate possible correlations of EGF concentrations with the severity of positive dimensions, overall psychopathology, total PANSS score and affective symptoms assessed with the Calgary Depression Scale for Schizophrenia (CDSS). The gene discussed is EGF; the disease is depressive disorder.